Story
Rocket Lab Shares Continue Slide as Investors Weigh Iridium Deal
Summary
Shares of Rocket Lab are extending their recent decline as investors analyze the financial risks of its planned $8 billion merger with Iridium Communications. The slide also comes amid a broader market downturn affecting growth-oriented technology stocks.
Shares of Rocket Lab (RKLB) continued their downward trend in recent trading sessions, extending a retreat that has erased initial gains following a major merger announcement. The stock has fallen approximately 16.7% over the past week from highs reached after the deal was revealed.
The investor pullback follows the June 28 announcement of an $8 billion merger with Iridium Communications. While the news initially sparked enthusiasm for creating a vertically integrated space and connectivity company, investor focus has reportedly shifted to the financial implications of the large-scale deal, including potential execution and leverage risks for Rocket Lab.
Despite the stock's decline, some analysts remain optimistic about the company's long-term prospects. Morgan Stanley reiterated its "Overweight" rating on Rocket Lab, maintaining a $105 price target and raising its bull case target to $293. The firm cited the strategic benefits and expanded market potential the Iridium deal could create.
AdBroader market conditions have also contributed to the pressure on Rocket Lab's stock. A general sell-off in the tech sector, with both the Nasdaq Composite and S&P 500 declining, has particularly impacted high-growth companies. This risk-off sentiment is affecting stocks like Rocket Lab, which trade at high valuations relative to current earnings despite reporting strong operational results, including record first-quarter revenue.